WHITEHOUSE STATION, N.J. (January 14, 2014 Merck & Co. is recalling its combination cholesterol drug Liptruzet, wiping out the entire U.S. stock, because of packaging defects that could reduce effectiveness.
Merck says the recall covers all four dose strengths and every batch distributed since Liptruzet was launched last May.
Merck, the world's third-biggest drug maker, says some of the foil pouches containing the pills may allow air and moisture inside.
Merck said there's a remote chance that could decrease the drug's effectiveness or otherwise change its properties, but that the recall is not because of any reports of patients who were harmed.
The Whitehouse Station, N.J., company says patients can continue taking any Liptruzet they have and should consult their doctors before stopping therapy.
Merck says it plans to get Liptruzet back on the market as soon as possible.